Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients

Clinical trial NCT04696705 · UNKNOWN

Trial details

NCT number: NCT04696705
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma (NHL)Peripheral T Cell Lymphoma (PTCL)

Start date: 2020-12-31
Primary completion: 2021-12-25
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.